Skip to main content
. 2000 Apr 1;20(7):2711–2718. doi: 10.1523/JNEUROSCI.20-07-02711.2000

Table 2.

Raw counts of nuclei for Experiment 2

Area Group 8arm-2 Group 8arm-novel
VISp 215.5  ± 13.9 220.7  ± 18.8
MOp 169.0  ± 14.0 165.7  ± 17.5
SSp 180.0  ± 14.0 178.6  ± 13.8
Peri 136.0  ± 15.9 155.8  ± 16.5
Post 117.0  ± 13.1 172.1  ± 12.5
Entl 59.4  ± 6.5 80.2  ± 9.8
Entmv 108.3  ± 10.6 160.2  ± 19.8
Subd 46.9  ± 6.8 87.3  ± 18.4
Subv 57.3  ± 6.6 71.1  ± 10.7
Subc 52.2  ± 7.4 78.6  ± 9.6
DG 10.5  ± 4.0 17.1  ± 2.7
CA3 12.7  ± 2.5 17.0  ± 3.2
CA1 9.6  ± 1.6 21.9  ± 3.3
Dorsal HPC 39.6  ± 5.6 91.3  ± 13.2
Ventral HPC 108.7  ± 10.4 149.6  ± 21.4

The mean counts ± SE of the number of Fos-stained nuclei for the given regions in Experiment 2. For areas VISp down to Subc, these numbers are taken from the standard frame sample area, which is equivalent to 0.43 mm2 (see Materials and Methods). For the remaining areas the counts are for the entire extent of the target region within the selected coronal sections. The mean counts for Experiment 2 are approximately twice those in Experiment 1. This general increase in staining is attributable to the use of a different batch of primary antibody. See Figure 1 for abbreviations.